Terapias Avanzadas para Enfermedades Hepáticas Raras
AAV4Cancer
![Foto de Terapias Avanzadas para Enfermedades Hepáticas Raras](/img/uploaded/f0cba6fe852c1cc84e13dd6b700bdc8f.jpg)
![Foto de London Health Sciences Centre](/img/noimage_org.png)
London Health Sciences Centre
London, CanadáLondon Health Sciences Centre-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2014
-
CD271 is a functional and targetable marker of tumor-initiating cells in head and neck squamous cell carcinoma
Oncotarget, Vol. 5, Núm. 16, pp. 6854-6866